Schenkein David P

Average Profitability
30.47%
Insider Buys Quantity
1
Insider Buys Sum
$199,920.00
Insider Sells Quantity
7
Insider Sells Sum
$8.57M

Insider Activity of Schenkein David P

According to the SEC Form 4 filings, Schenkein David P, being in a position of

  1. director at Denali Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 59441 share for $1.93M,
    over all time since 2020-11-04, has bought 0 shares, and sold 139441 share for $7.84M.

The largest purchase of all time was on 2014-12-19 and amounted to 2352 shares of bluebird bio, Inc. for $199,920.

The largest sale of all time was on 2020-12-21 and amounted to 30000 shares of Denali Therapeutics Inc. for $2.7M.

Biography of Schenkein David P

No biography is available at this moment.

2024-11-11SaleDenali Therapeutics Inc.
DNLI
director
59,441
0.0421%
$32.51$1.93M-20.68%
2020-12-21SaleDenali Therapeutics Inc.
DNLI
director
30,000
0.0248%
$90.05$2.7M-38.96%
2020-11-12SaleDenali Therapeutics Inc.
DNLI
director
30,000
0.025%
$70.05$2.1M-12.79%
2020-11-10SaleDenali Therapeutics Inc.
DNLI
director
10,000
0.0083%
$60.03$600,310+1.93%
2020-11-04SaleDenali Therapeutics Inc.
DNLI
director
10,000
0.0081%
$50.18$501,830+18.56%
2017-08-31Salebluebird bio, Inc.
BLUE
director
4,000
0.0043%
$61.61$246,457+37.81%
2017-03-01Salebluebird bio, Inc.
BLUE
director
10,000
0.0129%
$48.84$488,412+28.66%
2014-12-19Purchasebluebird bio, Inc.
BLUE
director
2,352
0.0074%
$85.00$199,920+30.47%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.